scx
Lv1
28 积分
2024-07-29 加入
-
Temporal trends in the treatment of relapsing minimal change podocytopathy – a binational cohort study
10小时前
已完结
-
Slow Coronary Flow: Pathophysiology, Clinical Implications, and Therapeutic Management
23天前
已完结
-
[The expanding needs on lipid-lowering treatment in patients with acute coronary syndrome by applying newly issued definition of extreme high-risk by Chinese Society of Cardiology]
4个月前
已完结
-
2024 ESC Guidelines for the management of chronic coronary syndromes
5个月前
已完结
-
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial
6个月前
已完结
-
Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
6个月前
已完结
-
PCSK9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Randomized, Double- Blind, Placebo-Controlled, Multicenter SHAWN Study
6个月前
已完结
-
Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases
9个月前
已完结